Event Specialty: Bronchoscopy
Alexander Chen, MD
Director, Interventional Pulmonology
Colorado Convention Center: Room 710 & 712
Update - Our presentation will now be hosted on Thursday, August 23 from 12:00 - 1:00pm.
Presentation includes first U.S. cases by the first and only robotic bronchoscopy platform.
Auris will host a lunch symposium at the upcoming Inaugural Conference of the AABIP in Denver, Colorado. Dr. Chen will speak about the past, present, and future clinical evidence generation plan for Auris’ Robotic Bronchoscopy system, called the Monarch Platform. Dr. Chen will also discuss several recently completed Robotic Bronchoscopy cases from here in the United States.
The Monarch Platform received U.S. Food and Drug Administration (FDA) clearance in March 2018 for diagnostic and therapeutic bronchoscopic procedures. The platform integrates the latest advancements in robotics, software, data science, and endoscope innovation. It features a familiar controller interface that physicians use to navigate the flexible robotic endoscope to the periphery of the lung with unprecedented reach, vision, and control.
The American Association for Bronchology and Interventional Pulmonology, with a long and well-established presence in its field, is hosting its first standalone conference in Denver from August 23 - 25. This event serves as a premier forum to examine current concepts and advances in minimally invasive techniques for the diagnosis, staging and management of patients with thoracic disease.
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.